Press Releases Search Search Category Topic Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc (-) Institute & Campus (8) Press release (67) Science (17) 3R principles (replace, reduce, refine) (1) Animal Research (1) Artificial Intelligence (2) BIH (6) BIMSB (4) Biochemistry & Proteomics (1) Campus (1) Campus Buch (1) Cancer (2) Cardiovascular Research (1) Cell Biology (2) (-) Charité (5) Communication (2) Construction (1) Corona Research (1) CRISPR/Cas9 (2) Data science (1) Developmental Biology (1) Disease-related Research (2) (-) ECRC (1) EU-Life (1) Genetics & Genomics (1) Green Campus (1) Helmholtz (1) History (1) Institute (6) LifeTime (1) Long Night of Sciences (1) (-) Organoids (3) Personalia (7) Prizes & Awards (4) Responsible Research (1) science policy (1) Single-cell analysis (4) Support for Scientists (1) (-) Systems Biology (2) Teachers & Pupils (1) Technology Platforms (1) Translation (2) We at the MDC (1) Women in Science (1) Work and Family (1) 8 Results: Active Filter: Institute & CampusCharitéECRCOrganoidsSystems Biology Sort: Result score Newest to oldest Oldest to newest Press Release No. 41 September 23, 2020 Berlin National Center for Tumor Diseases in Berlin Berlin will become one of four new National Center for Tumor Diseases (NCT) locations in addition to Heidelberg and Dresden. This was announced today by the Federal Ministry of Education and Research, recognizing the outstanding achievements of Charité, the BIH and the MDC in advancing cancer treatment and research. Press Release No. 5 February 10, 2020 Berlin Mass spectrometry for precision medicine Research groups from Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) are joining forces with other Berlin-based partners. Pooling their experience and outstanding expertise in the field of mass spectrometry, they will form a new ‘Forschungskern’ or ‘research core’. Press Release No. 40 August 30, 2019 Berlin MDC bids farewell to Charité’s head Karl Max Einhäupl and welcomes his successor Heyo Kroemer, lauding fair collaboration As Karl Max Einhäupl steps down as Chairman of the Charité’s Executive Board, Thomas Sommer, interim Scientific Director of the MDC, honors Einhäupl’s achievements and applauds him for the excellent and equitable collaboration. Sommer wishes the Charité’s new head, Heyo Kroemer, the very best and much success in his new position. Press Release No. 36 July 10, 2019 Berlin We are looking forward to the partnership with the BIH The administrative agreement is signed, the Berlin Institute of Health (BIH ) will become the third pillar of the Charité. "We are excited about the privileged partnership," says Professor Thomas Sommer, interim Scientific Director of the MDC. Press Release No. 28 June 06, 2019 Berlin Creative minds, CRISPR, and cats Anyone wishing to uncover the mysteries of life must explore the realm of molecules and genes. At the Long Night of the Sciences, visitors to the MDC will voyage through this fascinating cosmos in the company of experts. Press Release No. 13 April 05, 2019 Berlin MDC welcomes privileged partnership with the BIH The MDC welcomes the agreement reached between the State of Berlin and the federal government regarding the future of the Berlin Institute of Health (BIH ). The term “privileged partnership” has to now be filled with life and backed up with funding. Press Release No. 8 March 06, 2019 Berlin LifeTime is delighted to receive EU funding LifeTime is one of the six winners of an EU-wide competition in which ambitious and forward-looking research projects are selected and funded. This was officially announced by the European Commission on Tuesday. The coordinators of LifeTime in Berlin and Paris were pleased that they can now begin the actual work. Chancellor Merkel praised the initiative. Press Release No. 6 March 04, 2019 Berlin The avant-garde of genetic research is now in the heart of Berlin Chancellor Angela Merkel inaugurated on Tuesday the Max Delbrück Center’s new building in the heart of Berlin. Some 250 top researchers of the Berlin Institute for Medical Systems Biology (BIMSB) will use the facility to study how genes regulate the lives of cells and thus influence health and disease.